{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:33Z","timestamp":1761561933377},"reference-count":64,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"unspecified","delay-in-days":4322,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p>Parkinson's disease is a progressive neurodegenerative disorder that demands a holistic approach to treatment. Both pharmacologic and nonpharmacologic interventions play an important role in the comprehensive management of this disorder. While levodopa remains the single most effective medication for symptomatic treatment, dopamine agonists are playing an increasingly important role. Motor complications of dopaminergic therapy are a significant issue, particularly in patients with more advanced disease who have been on levodopa for several years. All therapeutic interventions must be tailored to the individual and modified as the disease progresses, with the goal of minimizing significant functional disability as much as possible.<\/jats:p>","DOI":"10.1017\/s0317167100003218","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T15:35:03Z","timestamp":1418398503000},"page":"S27-S33","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Parkinson's Disease"],"prefix":"10.1017","volume":"30","author":[{"given":"W.R. Wayne","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Wieler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"S0317167100003218_ref053","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200009)15:5<879::AID-MDS1018>3.0.CO;2-9"},{"key":"S0317167100003218_ref005","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.2_Part_1.202"},{"key":"S0317167100003218_ref036","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.13.1653"},{"key":"S0317167100003218_ref050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ptj\/80.6.578","article-title":"Movement disorders in people with Parkinson\u2019sdisease: a model for physical therapy","volume":"80","author":"Morris","year":"2000","journal-title":"Phys Ther"},{"key":"S0317167100003218_ref034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911163212004"},{"key":"S0317167100003218_ref058","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H"},{"key":"S0317167100003218_ref060","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530260049018"},{"key":"S0317167100003218_ref051","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-200101000-00011"},{"key":"S0317167100003218_ref032","first-page":"455","article-title":"Excessive daytimesleepiness and sudden-onset sleep in Parkinson\u2019s disease","volume":"287","author":"Hobson","year":"2002","journal-title":"A survey by the Canadian Movement Disorders Group. JAMA"},{"key":"S0317167100003218_ref028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401003"},{"key":"S0317167100003218_ref021","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1057"},{"key":"S0317167100003218_ref025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422004"},{"key":"S0317167100003218_ref016","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5942.442"},{"key":"S0317167100003218_ref063","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130108"},{"key":"S0317167100003218_ref044","volume-title":"The Cochrane Library","author":"Deane","year":"2002"},{"key":"S0317167100003218_ref018","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090107"},{"key":"S0317167100003218_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62690-1"},{"key":"S0317167100003218_ref012","first-page":"1012","article-title":"Immediate-release andcontrolled-release carbidopa\/levodopa in PD: a 5 year randomized multicenter study","volume":"53","author":"Koller","year":"1999","journal-title":"Carbidopa\/Levodopa Study Group. Neurology"},{"key":"S0317167100003218_ref026","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.15.1931"},{"key":"S0317167100003218_ref038","article-title":"Parkinson\u2019s disease nurse specialists: an importantrole in disease management","volume":"57","author":"MacMahon","year":"1999","journal-title":"Neurology"},{"key":"S0317167100003218_ref017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197612162952504"},{"key":"S0317167100003218_ref056","first-page":"166","article-title":"An interprofessional team approach torehabilitation in Parkinson\u2019s disease","volume":"6","author":"Morris","year":"1997","journal-title":"Eur J Phys Med Rehab"},{"key":"S0317167100003218_ref054","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.4.580"},{"key":"S0317167100003218_ref043","volume-title":"The Cochrane Library","author":"Deane","year":"2002"},{"key":"S0317167100003218_ref057","first-page":"549","article-title":"OccupationalTherapy and Physical Dysfunction","author":"Turner","year":"1996"},{"key":"S0317167100003218_ref015","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420511"},{"key":"S0317167100003218_ref062","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(01)00015-3"},{"key":"S0317167100003218_ref031","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.9.1908"},{"key":"S0317167100003218_ref042","article-title":"Management of Parkinson\u2019sdisease: an evidence-based review","volume":"17","author":"Goetz","year":"2002","journal-title":"Mov Disord"},{"key":"S0317167100003218_ref010","first-page":"163","article-title":"Patterns ofdystonia (\u201cI-D-I\u201d and \u201cD-I-D\u2013) in response to l-dopa therapy for Parkinson\u2019s disease","volume":"52","author":"Muenter","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"S0317167100003218_ref001","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1187"},{"key":"S0317167100003218_ref046","article-title":"Speech and language therapy for dysarthria in Parkinson\u2019s disease: a comparison of techniques (Cochrane Review)","author":"Deane","year":"2002","journal-title":"The Cochrane Library"},{"key":"S0317167100003218_ref040","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120614"},{"key":"S0317167100003218_ref037","article-title":"The REAL-PETstudy: slowerprogression in early Parkinson\u2019s disease treated with ropinirolecompared with l-dopa","volume":"58","author":"Whone","year":"2002","journal-title":"Neurology"},{"key":"S0317167100003218_ref030","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.789"},{"key":"S0317167100003218_ref020","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.4.1060"},{"key":"S0317167100003218_ref006","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.1051"},{"key":"S0317167100003218_ref048","article-title":"A model for multisystem evaluationtreatment of individuals with Parkinson\u2019s disease","volume":"932","author":"Schenkman","year":"1989","journal-title":"Phys Ther"},{"key":"S0317167100003218_ref064","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.3_Suppl_3.S1"},{"key":"S0317167100003218_ref035","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.2.520"},{"key":"S0317167100003218_ref024","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.5.749"},{"key":"S0317167100003218_ref008","article-title":"Palliative and prophylacticbenefits of continuously administered dopaminomimetics in Parkinson\u2019s disease","volume":"44","author":"Chase","year":"1994","journal-title":"Neurology"},{"key":"S0317167100003218_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.11.1383"},{"key":"S0317167100003218_ref014","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.1.36"},{"key":"S0317167100003218_ref019","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1.162"},{"key":"S0317167100003218_ref061","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.suppl_1.S79"},{"key":"S0317167100003218_ref002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.6.1142"},{"key":"S0317167100003218_ref047","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/77.11.1163"},{"key":"S0317167100003218_ref029","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B"},{"key":"S0317167100003218_ref041","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2001.22352"},{"key":"S0317167100003218_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70285-3"},{"key":"S0317167100003218_ref022","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199619030-00005"},{"key":"S0317167100003218_ref059","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.4.493"},{"key":"S0317167100003218_ref033","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1985.tb10556.x"},{"key":"S0317167100003218_ref007","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220415"},{"key":"S0317167100003218_ref027","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.1.11"},{"key":"S0317167100003218_ref004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391506"},{"key":"S0317167100003218_ref052","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.12.1532"},{"key":"S0317167100003218_ref045","article-title":"Speech and language therapy versus placebo or no intervention for dysarthria in Parkinson\u2019s disease (Cochrane Review)","author":"Deane","year":"2002","journal-title":"The Cochrane Library"},{"key":"S0317167100003218_ref049","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/69.11.944"},{"key":"S0317167100003218_ref013","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5_Suppl_5.S3"},{"key":"S0317167100003218_ref039","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.4.550"},{"key":"S0317167100003218_ref023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.8.1009"},{"key":"S0317167100003218_ref055","volume-title":"Motor Control and Learning: A Behavioral Emphasis","author":"Schmidt","year":"1999"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100003218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T21:45:13Z","timestamp":1598564713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100003218\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":64,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0317167100003218"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100003218","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}